Oruka Therapeutics
ORKA
NASDAQ
IPO2024
about ORKA
Oruka Therapeutics specializes in developing innovative cancer treatments using cutting-edge biotechnology and immuno-oncology approaches to address unmet medical needs.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $32.84 | $41.19 | $32.30 | $1.9B | 1.59M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| +$0.00 | n/a | n/a | 0% | 0% | 0% |